Rank | Gene Set | Z-score |
---|---|---|
1 | skeletal muscle contraction (GO:0003009) | 5.65263595 |
2 | desmosome organization (GO:0002934) | 4.74307540 |
3 | response to peptidoglycan (GO:0032494) | 4.67255541 |
4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.47651334 |
5 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.06348829 |
6 | NADH metabolic process (GO:0006734) | 3.85980492 |
7 | sarcomere organization (GO:0045214) | 3.83577159 |
8 | hemidesmosome assembly (GO:0031581) | 3.83343630 |
9 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.82353426 |
10 | pinocytosis (GO:0006907) | 3.79358110 |
11 | striated muscle atrophy (GO:0014891) | 3.73856300 |
12 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.70645148 |
13 | 2-oxoglutarate metabolic process (GO:0006103) | 3.64066780 |
14 | hepatocyte apoptotic process (GO:0097284) | 3.60004634 |
15 | regulation of water loss via skin (GO:0033561) | 3.59277342 |
16 | glycogen catabolic process (GO:0005980) | 3.51584518 |
17 | actin filament-based movement (GO:0030048) | 3.48468563 |
18 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.46997498 |
19 | glucan catabolic process (GO:0009251) | 3.44913471 |
20 | muscle filament sliding (GO:0030049) | 3.42913568 |
21 | actin-myosin filament sliding (GO:0033275) | 3.42913568 |
22 | low-density lipoprotein particle clearance (GO:0034383) | 3.37371768 |
23 | lysine metabolic process (GO:0006553) | 3.35600868 |
24 | lysine catabolic process (GO:0006554) | 3.35600868 |
25 | cellular polysaccharide catabolic process (GO:0044247) | 3.35352404 |
26 | fatty acid transmembrane transport (GO:1902001) | 3.35257379 |
27 | regulation of sequestering of triglyceride (GO:0010889) | 3.34560216 |
28 | response to muscle activity (GO:0014850) | 3.33658434 |
29 | striated muscle contraction (GO:0006941) | 3.28900295 |
30 | regulation of skeletal muscle contraction (GO:0014819) | 3.26918421 |
31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.26075751 |
32 | carnitine shuttle (GO:0006853) | 3.23375539 |
33 | positive regulation of lipid storage (GO:0010884) | 3.22591054 |
34 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.21939165 |
35 | protein carboxylation (GO:0018214) | 3.20988269 |
36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.20988269 |
37 | pentose-phosphate shunt (GO:0006098) | 3.20547285 |
38 | plasma lipoprotein particle clearance (GO:0034381) | 3.19604829 |
39 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.18478396 |
40 | protein localization to endosome (GO:0036010) | 3.15193374 |
41 | regulation of triglyceride catabolic process (GO:0010896) | 3.14605727 |
42 | muscle atrophy (GO:0014889) | 3.14460059 |
43 | valine metabolic process (GO:0006573) | 3.11725732 |
44 | plasma membrane repair (GO:0001778) | 3.11090636 |
45 | negative regulation of cell size (GO:0045792) | 3.10500242 |
46 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.10375484 |
47 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.10375484 |
48 | negative regulation of necroptotic process (GO:0060546) | 3.07937747 |
49 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.07698007 |
50 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.06432426 |
51 | focal adhesion assembly (GO:0048041) | 3.05284012 |
52 | cell-substrate adherens junction assembly (GO:0007045) | 3.05284012 |
53 | cell-substrate junction assembly (GO:0007044) | 3.00967186 |
54 | regulation of leukocyte degranulation (GO:0043300) | 3.00857786 |
55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.00606880 |
56 | positive regulation by symbiont of host defense response (GO:0052509) | 3.00365821 |
57 | modulation by symbiont of host defense response (GO:0052031) | 3.00365821 |
58 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.00365821 |
59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.00365821 |
60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.00365821 |
61 | modulation by symbiont of host immune response (GO:0052553) | 3.00365821 |
62 | polysaccharide catabolic process (GO:0000272) | 2.99791276 |
63 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.99175392 |
64 | glucose catabolic process (GO:0006007) | 2.98816127 |
65 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.98052654 |
66 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.97148440 |
67 | fatty acid beta-oxidation (GO:0006635) | 2.94992275 |
68 | establishment of skin barrier (GO:0061436) | 2.94655499 |
69 | phospholipid homeostasis (GO:0055091) | 2.93685455 |
70 | fructose metabolic process (GO:0006000) | 2.91678473 |
71 | complement activation, alternative pathway (GO:0006957) | 2.90786459 |
72 | regulation of cholesterol storage (GO:0010885) | 2.89283619 |
73 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.89265960 |
74 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.89265960 |
75 | detection of other organism (GO:0098543) | 2.88069091 |
76 | glyoxylate metabolic process (GO:0046487) | 2.88029501 |
77 | mannose metabolic process (GO:0006013) | 2.87656144 |
78 | carnitine metabolic process (GO:0009437) | 2.86957866 |
79 | kynurenine metabolic process (GO:0070189) | 2.86700587 |
80 | amino-acid betaine metabolic process (GO:0006577) | 2.85630153 |
81 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.83547279 |
82 | myofibril assembly (GO:0030239) | 2.83509066 |
83 | sulfur amino acid catabolic process (GO:0000098) | 2.83251469 |
84 | regulation of necrotic cell death (GO:0010939) | 2.82831785 |
85 | amyloid precursor protein metabolic process (GO:0042982) | 2.82369479 |
86 | alpha-linolenic acid metabolic process (GO:0036109) | 2.82033431 |
87 | L-phenylalanine metabolic process (GO:0006558) | 2.81362791 |
88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.81362791 |
89 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.80823206 |
90 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.80754439 |
91 | skeletal muscle fiber development (GO:0048741) | 2.79245170 |
92 | regulation of necroptotic process (GO:0060544) | 2.77505611 |
93 | glycosphingolipid catabolic process (GO:0046479) | 2.77437777 |
94 | activation of Rac GTPase activity (GO:0032863) | 2.76323535 |
95 | cysteine metabolic process (GO:0006534) | 2.75065916 |
96 | actin-mediated cell contraction (GO:0070252) | 2.73729421 |
97 | fatty acid oxidation (GO:0019395) | 2.73479227 |
98 | detection of bacterium (GO:0016045) | 2.73244833 |
99 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.72985950 |
100 | ethanol oxidation (GO:0006069) | 2.72757896 |
101 | urea metabolic process (GO:0019627) | 2.72308847 |
102 | urea cycle (GO:0000050) | 2.72308847 |
103 | oxaloacetate metabolic process (GO:0006107) | 2.71232724 |
104 | membrane raft organization (GO:0031579) | 2.70971362 |
105 | COPI coating of Golgi vesicle (GO:0048205) | 2.70857310 |
106 | Golgi transport vesicle coating (GO:0048200) | 2.70857310 |
107 | positive regulation of myotube differentiation (GO:0010831) | 2.70002074 |
108 | lipid oxidation (GO:0034440) | 2.69722409 |
109 | tricarboxylic acid metabolic process (GO:0072350) | 2.68738000 |
110 | cardiac myofibril assembly (GO:0055003) | 2.68666180 |
111 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.66700712 |
112 | response to muramyl dipeptide (GO:0032495) | 2.66700705 |
113 | tricarboxylic acid cycle (GO:0006099) | 2.64534085 |
114 | neutrophil mediated immunity (GO:0002446) | 2.63611630 |
115 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.63158128 |
116 | L-phenylalanine catabolic process (GO:0006559) | 2.62575800 |
117 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.62575800 |
118 | fatty acid catabolic process (GO:0009062) | 2.62569892 |
119 | NADPH regeneration (GO:0006740) | 2.62556251 |
120 | neutrophil activation involved in immune response (GO:0002283) | 2.61781026 |
121 | negative regulation of fibrinolysis (GO:0051918) | 2.61735000 |
122 | galactose catabolic process (GO:0019388) | 2.61623546 |
123 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.60257994 |
124 | positive regulation of p38MAPK cascade (GO:1900745) | 2.59993423 |
125 | carnitine transmembrane transport (GO:1902603) | 2.58887231 |
126 | maternal placenta development (GO:0001893) | 2.57755360 |
127 | regulation of mast cell degranulation (GO:0043304) | 2.57483682 |
128 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.57376293 |
129 | apoptotic cell clearance (GO:0043277) | 2.57241733 |
130 | skeletal muscle adaptation (GO:0043501) | 2.56441958 |
131 | positive regulation of lipid catabolic process (GO:0050996) | 2.56413284 |
132 | neutrophil activation (GO:0042119) | 2.55479378 |
133 | regulation of fatty acid oxidation (GO:0046320) | 2.55079124 |
134 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.53980273 |
135 | regulation of protein activation cascade (GO:2000257) | 2.52075151 |
136 | nitrogen cycle metabolic process (GO:0071941) | 2.51838404 |
137 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.51738374 |
138 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.51097013 |
139 | hypotonic response (GO:0006971) | 2.50856223 |
140 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.50397616 |
141 | positive regulation of epidermis development (GO:0045684) | 2.49624746 |
142 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.49235128 |
143 | adherens junction assembly (GO:0034333) | 2.48703225 |
144 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.48623208 |
145 | macrophage activation involved in immune response (GO:0002281) | 2.48181174 |
146 | creatine metabolic process (GO:0006600) | 2.47857890 |
147 | actomyosin structure organization (GO:0031032) | 2.47514767 |
148 | amyloid precursor protein catabolic process (GO:0042987) | 2.45308299 |
149 | regulation of regulated secretory pathway (GO:1903305) | 2.44748952 |
150 | carnitine transport (GO:0015879) | 2.44610999 |
151 | amino-acid betaine transport (GO:0015838) | 2.44610999 |
152 | glycogen biosynthetic process (GO:0005978) | 2.44437557 |
153 | glucan biosynthetic process (GO:0009250) | 2.44437557 |
154 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.44103222 |
155 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.43928448 |
156 | reactive oxygen species biosynthetic process (GO:1903409) | 2.43782267 |
157 | glycolipid catabolic process (GO:0019377) | 2.43605692 |
158 | aromatic amino acid family catabolic process (GO:0009074) | 2.42774392 |
159 | regulation of complement activation (GO:0030449) | 2.42284617 |
160 | regulation of relaxation of muscle (GO:1901077) | 2.41584418 |
161 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.41250513 |
162 | glucose 6-phosphate metabolic process (GO:0051156) | 2.41180522 |
163 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.41113282 |
164 | monocarboxylic acid catabolic process (GO:0072329) | 2.40914009 |
165 | aspartate family amino acid catabolic process (GO:0009068) | 2.40419657 |
166 | granulocyte activation (GO:0036230) | 2.39754125 |
167 | 4-hydroxyproline metabolic process (GO:0019471) | 2.38876550 |
168 | killing of cells of other organism (GO:0031640) | 2.38576213 |
169 | disruption of cells of other organism (GO:0044364) | 2.38576213 |
170 | acute-phase response (GO:0006953) | 2.38504065 |
171 | acetyl-CoA metabolic process (GO:0006084) | 2.37126985 |
172 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.36629418 |
173 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.36185190 |
174 | heart process (GO:0003015) | 2.35990926 |
175 | heart contraction (GO:0060047) | 2.35990926 |
176 | negative regulation of interleukin-8 production (GO:0032717) | 2.35523850 |
177 | multicellular organismal water homeostasis (GO:0050891) | 2.33476638 |
178 | epithelial cell-cell adhesion (GO:0090136) | 2.31770315 |
179 | striated muscle adaptation (GO:0014888) | 2.31695373 |
180 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.29403284 |
181 | glycogen metabolic process (GO:0005977) | 2.27216532 |
182 | cellular glucan metabolic process (GO:0006073) | 2.27176834 |
183 | glucan metabolic process (GO:0044042) | 2.27176834 |
184 | cardiac muscle contraction (GO:0060048) | 2.26960200 |
185 | cellular extravasation (GO:0045123) | 2.26691787 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.60951848 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.52178396 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.99858198 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.86424487 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.75230112 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.22837962 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.07683113 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.66062198 |
9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.52737212 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.52579957 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.49158381 |
12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.34021954 |
13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.25272541 |
14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.23446674 |
15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23377271 |
16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.19356597 |
17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19260269 |
18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18195791 |
19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.06768748 |
20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.06765843 |
21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.05283731 |
22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.03457917 |
23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.02490922 |
24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.99629447 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.98405032 |
26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94987180 |
27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91234669 |
28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90227877 |
29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90072603 |
30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.88835098 |
31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84507890 |
32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.76182533 |
33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75753451 |
34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74758611 |
35 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70249902 |
36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69347209 |
37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.68326879 |
38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66669578 |
39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65764496 |
40 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.61955062 |
41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57501859 |
42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56355219 |
43 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.55188843 |
44 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.51173048 |
45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49454054 |
46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49401704 |
47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.45229954 |
48 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.43993710 |
49 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.36151902 |
50 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.36151902 |
51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35236289 |
52 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.34769606 |
53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32530967 |
54 | MAF_26560356_Chip-Seq_TH1_Human | 1.31361212 |
55 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.29419331 |
56 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.29090723 |
57 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.26563113 |
58 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26446214 |
59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25972013 |
60 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25882189 |
61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25766274 |
62 | P68_20966046_ChIP-Seq_HELA_Human | 1.22886974 |
63 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22434950 |
64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22142419 |
65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20960230 |
66 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.19672921 |
67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19586179 |
68 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19349674 |
69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17808415 |
70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15912084 |
71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15814686 |
72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15670160 |
73 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14714004 |
74 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.14471849 |
75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13921584 |
76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13135270 |
77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12897193 |
78 | MAF_26560356_Chip-Seq_TH2_Human | 1.12447611 |
79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.11477980 |
80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10973867 |
81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10863061 |
82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10558860 |
83 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09039049 |
84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08988200 |
85 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08621076 |
86 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08585199 |
87 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.08480747 |
88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08399416 |
89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07896196 |
90 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07815145 |
91 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07721876 |
92 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07516229 |
93 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07217273 |
94 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.05929533 |
95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05642160 |
96 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05596765 |
97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05162955 |
98 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05043145 |
99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04931919 |
100 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04779308 |
101 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04741994 |
102 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04040551 |
103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03920103 |
104 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03730640 |
105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02918531 |
106 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02421654 |
107 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02329402 |
108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02087647 |
109 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01524668 |
110 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00800517 |
111 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00614396 |
112 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99276597 |
113 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99147562 |
114 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99109469 |
115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99044997 |
116 | MYC_22102868_ChIP-Seq_BL_Human | 0.98846580 |
117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98548178 |
118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98537164 |
119 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98073299 |
120 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.97529862 |
121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96924089 |
122 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96545062 |
123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96192881 |
124 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95617853 |
125 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95350526 |
126 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93203546 |
127 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92716211 |
128 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92401580 |
129 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92048382 |
130 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91395330 |
131 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.90672476 |
132 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90453999 |
133 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89811232 |
134 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88673331 |
135 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.88578956 |
136 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88463291 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005451_abnormal_body_composition | 4.17187503 |
2 | MP0010234_abnormal_vibrissa_follicle | 3.64171034 |
3 | MP0002837_dystrophic_cardiac_calcinosis | 3.15702823 |
4 | MP0002139_abnormal_hepatobiliary_system | 3.09053275 |
5 | MP0002796_impaired_skin_barrier | 2.99441835 |
6 | MP0005360_urolithiasis | 2.96216991 |
7 | MP0003646_muscle_fatigue | 2.95929265 |
8 | MP0009840_abnormal_foam_cell | 2.63162465 |
9 | MP0004264_abnormal_extraembryonic_tissu | 2.52828849 |
10 | MP0003303_peritoneal_inflammation | 2.39844017 |
11 | MP0005085_abnormal_gallbladder_physiolo | 2.38059002 |
12 | MP0003436_decreased_susceptibility_to | 2.31174898 |
13 | MP0000751_myopathy | 2.29563944 |
14 | MP0005365_abnormal_bile_salt | 2.22159989 |
15 | MP0004233_abnormal_muscle_weight | 2.22085816 |
16 | MP0004185_abnormal_adipocyte_glucose | 2.21247712 |
17 | MP0000749_muscle_degeneration | 2.19393614 |
18 | MP0004084_abnormal_cardiac_muscle | 2.18204688 |
19 | MP0008260_abnormal_autophagy | 2.17110697 |
20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.04831068 |
21 | MP0004145_abnormal_muscle_electrophysio | 2.01515885 |
22 | MP0000343_altered_response_to | 2.00539159 |
23 | MP0003806_abnormal_nucleotide_metabolis | 1.94190604 |
24 | MP0005076_abnormal_cell_differentiation | 1.93628557 |
25 | MP0003191_abnormal_cellular_cholesterol | 1.90001169 |
26 | MP0003705_abnormal_hypodermis_morpholog | 1.87070840 |
27 | MP0003453_abnormal_keratinocyte_physiol | 1.86893734 |
28 | MP0004130_abnormal_muscle_cell | 1.85883501 |
29 | MP0004036_abnormal_muscle_relaxation | 1.85181317 |
30 | MP0003724_increased_susceptibility_to | 1.84353916 |
31 | MP0005501_abnormal_skin_physiology | 1.84135017 |
32 | MP0005330_cardiomyopathy | 1.83800471 |
33 | MP0005083_abnormal_biliary_tract | 1.81136642 |
34 | MP0009785_altered_susceptibility_to | 1.77221096 |
35 | MP0004510_myositis | 1.76431597 |
36 | MP0000750_abnormal_muscle_regeneration | 1.70941836 |
37 | MP0003828_pulmonary_edema | 1.70777303 |
38 | MP0003300_gastrointestinal_ulcer | 1.66947039 |
39 | MP0003252_abnormal_bile_duct | 1.66412264 |
40 | MP0004087_abnormal_muscle_fiber | 1.62498718 |
41 | MP0005058_abnormal_lysosome_morphology | 1.58225540 |
42 | MP0002419_abnormal_innate_immunity | 1.57540998 |
43 | MP0010329_abnormal_lipoprotein_level | 1.57309627 |
44 | MP0004381_abnormal_hair_follicle | 1.57274023 |
45 | MP0001835_abnormal_antigen_presentation | 1.51795667 |
46 | MP0005319_abnormal_enzyme/_coenzyme | 1.51285516 |
47 | MP0004215_abnormal_myocardial_fiber | 1.50137204 |
48 | MP0005025_abnormal_response_to | 1.48042299 |
49 | MP0001853_heart_inflammation | 1.46887255 |
50 | MP0000579_abnormal_nail_morphology | 1.44682405 |
51 | MP0003656_abnormal_erythrocyte_physiolo | 1.42555256 |
52 | MP0009764_decreased_sensitivity_to | 1.42056479 |
53 | MP0005464_abnormal_platelet_physiology | 1.41364348 |
54 | MP0001216_abnormal_epidermal_layer | 1.40126542 |
55 | MP0000733_abnormal_muscle_development | 1.39052648 |
56 | MP0000609_abnormal_liver_physiology | 1.35793857 |
57 | MP0003566_abnormal_cell_adhesion | 1.35650365 |
58 | MP0002972_abnormal_cardiac_muscle | 1.35370465 |
59 | MP0002060_abnormal_skin_morphology | 1.33683153 |
60 | MP0010678_abnormal_skin_adnexa | 1.33125471 |
61 | MP0003195_calcinosis | 1.32906563 |
62 | MP0000467_abnormal_esophagus_morphology | 1.32246187 |
63 | MP0010630_abnormal_cardiac_muscle | 1.30754977 |
64 | MP0001533_abnormal_skeleton_physiology | 1.30377973 |
65 | MP0005385_cardiovascular_system_phenoty | 1.28516407 |
66 | MP0001544_abnormal_cardiovascular_syste | 1.28516407 |
67 | MP0002877_abnormal_melanocyte_morpholog | 1.27510899 |
68 | MP0009278_abnormal_bone_marrow | 1.26412375 |
69 | MP0002106_abnormal_muscle_physiology | 1.25289411 |
70 | MP0008469_abnormal_protein_level | 1.25185492 |
71 | MP0002138_abnormal_hepatobiliary_system | 1.25009082 |
72 | MP0003221_abnormal_cardiomyocyte_apopto | 1.24909211 |
73 | MP0004947_skin_inflammation | 1.24312933 |
74 | MP0005332_abnormal_amino_acid | 1.23878473 |
75 | MP0002148_abnormal_hypersensitivity_rea | 1.23370073 |
76 | MP0003186_abnormal_redox_activity | 1.20758474 |
77 | MP0002269_muscular_atrophy | 1.19159294 |
78 | MP0003172_abnormal_lysosome_physiology | 1.17693829 |
79 | MP0010368_abnormal_lymphatic_system | 1.17369304 |
80 | MP0003075_altered_response_to | 1.17117032 |
81 | MP0002118_abnormal_lipid_homeostasis | 1.11943099 |
82 | MP0002098_abnormal_vibrissa_morphology | 1.11603595 |
83 | MP0005620_abnormal_muscle_contractility | 1.11492788 |
84 | MP0005000_abnormal_immune_tolerance | 1.11178825 |
85 | MP0005166_decreased_susceptibility_to | 1.09460892 |
86 | MP0001845_abnormal_inflammatory_respons | 1.09097463 |
87 | MP0000747_muscle_weakness | 1.08961224 |
88 | MP0005666_abnormal_adipose_tissue | 1.08325576 |
89 | MP0000858_altered_metastatic_potential | 1.06653679 |
90 | MP0008775_abnormal_heart_ventricle | 1.05866127 |
91 | MP0001666_abnormal_nutrient_absorption | 1.05775962 |
92 | MP0005375_adipose_tissue_phenotype | 1.05161452 |
93 | MP0005023_abnormal_wound_healing | 1.05061271 |
94 | MP0004782_abnormal_surfactant_physiolog | 1.04384618 |
95 | MP0001849_ear_inflammation | 1.03866861 |
96 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03716645 |
97 | MP0006082_CNS_inflammation | 1.03296414 |
98 | MP0006036_abnormal_mitochondrial_physio | 1.02813791 |
99 | MP0002396_abnormal_hematopoietic_system | 1.01835889 |
100 | MP0010155_abnormal_intestine_physiology | 1.01423450 |
101 | MP0009931_abnormal_skin_appearance | 1.00790334 |
102 | MP0008438_abnormal_cutaneous_collagen | 1.00029409 |
103 | MP0000759_abnormal_skeletal_muscle | 0.99804618 |
104 | MP0000685_abnormal_immune_system | 0.99754449 |
105 | MP0005266_abnormal_metabolism | 0.97828130 |
106 | MP0010352_gastrointestinal_tract_polyps | 0.96872962 |
107 | MP0001545_abnormal_hematopoietic_system | 0.96610655 |
108 | MP0005397_hematopoietic_system_phenotyp | 0.96610655 |
109 | MP0005167_abnormal_blood-brain_barrier | 0.96409189 |
110 | MP0009763_increased_sensitivity_to | 0.96359274 |
111 | MP0002452_abnormal_antigen_presenting | 0.95992861 |
112 | MP0005409_darkened_coat_color | 0.95907608 |
113 | MP0006138_congestive_heart_failure | 0.93719203 |
114 | MP0000383_abnormal_hair_follicle | 0.93560036 |
115 | MP0003279_aneurysm | 0.93487405 |
116 | MP0005387_immune_system_phenotype | 0.92137749 |
117 | MP0001790_abnormal_immune_system | 0.92137749 |
118 | MP0004484_altered_response_of | 0.92107858 |
119 | MP0005165_increased_susceptibility_to | 0.91960108 |
120 | MP0000377_abnormal_hair_follicle | 0.90695176 |
121 | MP0009643_abnormal_urine_homeostasis | 0.90629844 |
122 | MP0005369_muscle_phenotype | 0.90258899 |
123 | MP0002166_altered_tumor_susceptibility | 0.90190759 |
124 | MP0000604_amyloidosis | 0.88225686 |
125 | MP0002723_abnormal_immune_serum | 0.87984156 |
126 | MP0000762_abnormal_tongue_morphology | 0.87897276 |
127 | MP0002332_abnormal_exercise_endurance | 0.87391410 |
128 | MP0001873_stomach_inflammation | 0.84858632 |
129 | MP0000598_abnormal_liver_morphology | 0.83555848 |
130 | MP0000249_abnormal_blood_vessel | 0.82627890 |
131 | MP0001958_emphysema | 0.82612449 |
132 | MP0001800_abnormal_humoral_immune | 0.82582275 |
133 | MP0002405_respiratory_system_inflammati | 0.82559681 |
134 | MP0010771_integument_phenotype | 0.81923300 |
135 | MP0009333_abnormal_splenocyte_physiolog | 0.80702230 |
136 | MP0000678_abnormal_parathyroid_gland | 0.74451386 |
137 | MP0002998_abnormal_bone_remodeling | 0.70933803 |
138 | MP0005248_abnormal_Harderian_gland | 0.69755165 |
139 | MP0001819_abnormal_immune_cell | 0.69132576 |
140 | MP0002420_abnormal_adaptive_immunity | 0.69062129 |
141 | MP0003329_amyloid_beta_deposits | 0.67302237 |
142 | MP0003763_abnormal_thymus_physiology | 0.65956480 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myopathic facies (HP:0002058) | 4.34327376 |
2 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.22639784 |
3 | Distal lower limb amyotrophy (HP:0008944) | 4.03196167 |
4 | Exercise-induced muscle cramps (HP:0003710) | 3.94011038 |
5 | Ventricular tachycardia (HP:0004756) | 3.79265250 |
6 | Asymmetric septal hypertrophy (HP:0001670) | 3.70493024 |
7 | Exercise-induced myalgia (HP:0003738) | 3.60584120 |
8 | Sudden death (HP:0001699) | 3.59246766 |
9 | Right ventricular cardiomyopathy (HP:0011663) | 3.48699922 |
10 | Muscle fiber splitting (HP:0003555) | 3.46886222 |
11 | Calf muscle hypertrophy (HP:0008981) | 3.46105763 |
12 | Increased connective tissue (HP:0009025) | 3.43517082 |
13 | Neck muscle weakness (HP:0000467) | 3.43123783 |
14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.42525510 |
15 | Myoglobinuria (HP:0002913) | 3.32322674 |
16 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.22923696 |
17 | Hyporeflexia of lower limbs (HP:0002600) | 3.19684655 |
18 | Xanthomatosis (HP:0000991) | 3.13100394 |
19 | Deep venous thrombosis (HP:0002625) | 3.12536305 |
20 | Progressive muscle weakness (HP:0003323) | 3.10422246 |
21 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.06962357 |
22 | Eczematoid dermatitis (HP:0000976) | 3.02832041 |
23 | Lipoatrophy (HP:0100578) | 2.98409074 |
24 | Muscle fiber inclusion bodies (HP:0100299) | 2.88129372 |
25 | Rhabdomyolysis (HP:0003201) | 2.85508220 |
26 | EMG: myopathic abnormalities (HP:0003458) | 2.84117848 |
27 | Axonal loss (HP:0003447) | 2.83234696 |
28 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.77818388 |
29 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.77534256 |
30 | Bulbar palsy (HP:0001283) | 2.76262957 |
31 | Recurrent abscess formation (HP:0002722) | 2.74456097 |
32 | Palpitations (HP:0001962) | 2.71565601 |
33 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.69152607 |
34 | Subaortic stenosis (HP:0001682) | 2.69152607 |
35 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.69082126 |
36 | Intrahepatic cholestasis (HP:0001406) | 2.67231463 |
37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.66080529 |
38 | Abnormality of the calf musculature (HP:0001430) | 2.64503731 |
39 | Systemic lupus erythematosus (HP:0002725) | 2.60682651 |
40 | Ragged-red muscle fibers (HP:0003200) | 2.59316447 |
41 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.56092850 |
42 | Hypoglycemic coma (HP:0001325) | 2.55874309 |
43 | Abnormality of nail color (HP:0100643) | 2.55292412 |
44 | Recurrent bacterial skin infections (HP:0005406) | 2.54951113 |
45 | Abnormality of macrophages (HP:0004311) | 2.52686557 |
46 | Round ear (HP:0100830) | 2.52198372 |
47 | Nausea (HP:0002018) | 2.51722787 |
48 | Prolonged partial thromboplastin time (HP:0003645) | 2.51225510 |
49 | Hyperammonemia (HP:0001987) | 2.51209964 |
50 | Difficulty running (HP:0009046) | 2.51124135 |
51 | Hypoalphalipoproteinemia (HP:0003233) | 2.50808615 |
52 | Complement deficiency (HP:0004431) | 2.50075634 |
53 | Hyperlipoproteinemia (HP:0010980) | 2.48275143 |
54 | Ketosis (HP:0001946) | 2.47704306 |
55 | Vacuolated lymphocytes (HP:0001922) | 2.46009642 |
56 | Type 1 muscle fiber predominance (HP:0003803) | 2.44936761 |
57 | Lower limb amyotrophy (HP:0007210) | 2.44581336 |
58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.41092370 |
59 | Myocardial infarction (HP:0001658) | 2.39683914 |
60 | Joint hemorrhage (HP:0005261) | 2.39272647 |
61 | Dilated cardiomyopathy (HP:0001644) | 2.38432008 |
62 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.36633386 |
63 | Nemaline bodies (HP:0003798) | 2.36239802 |
64 | Increased variability in muscle fiber diameter (HP:0003557) | 2.35725741 |
65 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.35168523 |
66 | Atrial fibrillation (HP:0005110) | 2.30545105 |
67 | EMG: neuropathic changes (HP:0003445) | 2.24441784 |
68 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.24379488 |
69 | Ketoacidosis (HP:0001993) | 2.22203804 |
70 | Esophageal neoplasm (HP:0100751) | 2.21901682 |
71 | Neoplasm of head and neck (HP:0012288) | 2.21901682 |
72 | Increased serum ferritin (HP:0003281) | 2.19804457 |
73 | Difficulty climbing stairs (HP:0003551) | 2.19269953 |
74 | Hypolipoproteinemia (HP:0010981) | 2.18329177 |
75 | Abnormality of complement system (HP:0005339) | 2.17087224 |
76 | Areflexia of lower limbs (HP:0002522) | 2.15012416 |
77 | Distal lower limb muscle weakness (HP:0009053) | 2.13911421 |
78 | Dicarboxylic aciduria (HP:0003215) | 2.13472362 |
79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.13472362 |
80 | Muscle stiffness (HP:0003552) | 2.12047031 |
81 | Broad face (HP:0000283) | 2.11772224 |
82 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.11427921 |
83 | Primary atrial arrhythmia (HP:0001692) | 2.11046057 |
84 | Fatigable weakness (HP:0003473) | 2.09542425 |
85 | Abnormality of the neuromuscular junction (HP:0003398) | 2.09542425 |
86 | Thick nail (HP:0001805) | 2.08703263 |
87 | Esophageal varix (HP:0002040) | 2.08441737 |
88 | Fatigue (HP:0012378) | 2.07757477 |
89 | Abnormality of iron homeostasis (HP:0011031) | 2.07363208 |
90 | Distal arthrogryposis (HP:0005684) | 2.06420984 |
91 | Facial diplegia (HP:0001349) | 2.05448509 |
92 | Malignant hyperthermia (HP:0002047) | 2.04979920 |
93 | Interstitial pulmonary disease (HP:0006530) | 2.04803770 |
94 | Hypercholesterolemia (HP:0003124) | 2.03517118 |
95 | Supraventricular tachycardia (HP:0004755) | 2.03497939 |
96 | Abnormality of proline metabolism (HP:0010907) | 2.02073322 |
97 | Hydroxyprolinuria (HP:0003080) | 2.02073322 |
98 | Supraventricular arrhythmia (HP:0005115) | 2.01511741 |
99 | Hypobetalipoproteinemia (HP:0003563) | 2.01493736 |
100 | Hyperglycinuria (HP:0003108) | 2.01464684 |
101 | Achilles tendon contracture (HP:0001771) | 2.01143191 |
102 | Micronodular cirrhosis (HP:0001413) | 2.00314017 |
103 | Foot dorsiflexor weakness (HP:0009027) | 2.00310253 |
104 | Rimmed vacuoles (HP:0003805) | 1.99220514 |
105 | Amyloidosis (HP:0011034) | 1.99087735 |
106 | Diaphragmatic weakness (HP:0009113) | 1.98602950 |
107 | Alopecia of scalp (HP:0002293) | 1.97362479 |
108 | Flat acetabular roof (HP:0003180) | 1.96926845 |
109 | Bundle branch block (HP:0011710) | 1.96858120 |
110 | Milia (HP:0001056) | 1.96388337 |
111 | Paralysis (HP:0003470) | 1.95030825 |
112 | Atrioventricular block (HP:0001678) | 1.94901717 |
113 | Generalized muscle weakness (HP:0003324) | 1.94130761 |
114 | Frequent falls (HP:0002359) | 1.93532301 |
115 | Increased cerebral lipofuscin (HP:0011813) | 1.93512162 |
116 | Ulnar deviation of the wrist (HP:0003049) | 1.93179881 |
117 | Ridged nail (HP:0001807) | 1.92172632 |
118 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.92090148 |
119 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.92090148 |
120 | Abnormality of glycolipid metabolism (HP:0010969) | 1.92090148 |
121 | Cholelithiasis (HP:0001081) | 1.91956564 |
122 | Short nail (HP:0001799) | 1.90664654 |
123 | Hematochezia (HP:0002573) | 1.89966857 |
124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89738714 |
125 | Generalized aminoaciduria (HP:0002909) | 1.89333632 |
126 | Gingival bleeding (HP:0000225) | 1.88780036 |
127 | Easy fatigability (HP:0003388) | 1.88217782 |
128 | Abnormality of the foot musculature (HP:0001436) | 1.87764783 |
129 | Skin nodule (HP:0200036) | 1.87580640 |
130 | Plantar hyperkeratosis (HP:0007556) | 1.87153810 |
131 | Onycholysis (HP:0001806) | 1.85581718 |
132 | Myotonia (HP:0002486) | 1.85440195 |
133 | Abnormal atrioventricular conduction (HP:0005150) | 1.85259699 |
134 | Abnormality of the intrinsic pathway (HP:0010989) | 1.85202711 |
135 | Heart block (HP:0012722) | 1.84645344 |
136 | Urticaria (HP:0001025) | 1.84148133 |
137 | Polycythemia (HP:0001901) | 1.83094895 |
138 | Abnormality of purine metabolism (HP:0004352) | 1.82351142 |
139 | Tetraparesis (HP:0002273) | 1.82339421 |
140 | Nail dystrophy (HP:0008404) | 1.81746717 |
141 | Limb-girdle muscle atrophy (HP:0003797) | 1.81701321 |
142 | Ventricular arrhythmia (HP:0004308) | 1.81425680 |
143 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.80924147 |
144 | Pili torti (HP:0003777) | 1.79465526 |
145 | Fragile nails (HP:0001808) | 1.76585453 |
146 | Abnormality of the Achilles tendon (HP:0005109) | 1.75537229 |
147 | Scapular winging (HP:0003691) | 1.72490823 |
148 | Gingivitis (HP:0000230) | 1.71747023 |
149 | Osteolytic defects of the hand bones (HP:0009699) | 1.71521676 |
150 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.71521676 |
151 | Increased IgE level (HP:0003212) | 1.71016126 |
152 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.70255580 |
153 | Trismus (HP:0000211) | 1.68087690 |
154 | J-shaped sella turcica (HP:0002680) | 1.67018863 |
155 | Hyperkalemia (HP:0002153) | 1.65794373 |
156 | Weak cry (HP:0001612) | 1.64833451 |
157 | Generalized amyotrophy (HP:0003700) | 1.64263865 |
158 | Microglossia (HP:0000171) | 1.63500779 |
159 | Abnormal blistering of the skin (HP:0008066) | 1.59832621 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 4.46620684 |
2 | ERN1 | 3.54618930 |
3 | PKN2 | 3.23299197 |
4 | TRIB3 | 3.10865405 |
5 | OBSCN | 2.79274041 |
6 | BCKDK | 2.70284589 |
7 | TBK1 | 2.37486626 |
8 | MAP2K3 | 2.29058615 |
9 | FLT3 | 2.14346322 |
10 | PRPF4B | 2.13575281 |
11 | MYLK | 2.01615760 |
12 | MAP3K3 | 1.90946359 |
13 | KIT | 1.89524432 |
14 | SMG1 | 1.87998977 |
15 | TYK2 | 1.81750483 |
16 | EPHB1 | 1.78357065 |
17 | TESK2 | 1.69786915 |
18 | RIPK4 | 1.65109138 |
19 | TAOK3 | 1.59827930 |
20 | RIPK1 | 1.54647873 |
21 | MAP3K11 | 1.54392166 |
22 | TIE1 | 1.53469094 |
23 | MAP4K1 | 1.50853655 |
24 | TESK1 | 1.47043380 |
25 | DMPK | 1.46861105 |
26 | IRAK3 | 1.44579211 |
27 | MST1R | 1.42951436 |
28 | PHKG1 | 1.41223469 |
29 | PHKG2 | 1.41223469 |
30 | BLK | 1.39776933 |
31 | LMTK2 | 1.39122562 |
32 | TGFBR2 | 1.35200977 |
33 | SIK1 | 1.34311274 |
34 | PIM2 | 1.31881403 |
35 | PTK6 | 1.31734230 |
36 | PIK3CA | 1.31491806 |
37 | TRPM7 | 1.29334126 |
38 | MAPKAPK3 | 1.26129226 |
39 | EEF2K | 1.23551747 |
40 | NEK9 | 1.23530187 |
41 | MAP3K14 | 1.21813261 |
42 | ICK | 1.18942827 |
43 | GRK6 | 1.17289657 |
44 | FGFR4 | 1.16412127 |
45 | NME2 | 1.13166833 |
46 | ABL2 | 1.11115049 |
47 | LRRK2 | 1.10940019 |
48 | KDR | 1.09212736 |
49 | PIK3CG | 1.09135429 |
50 | CDK12 | 1.00840791 |
51 | ZAP70 | 0.99157499 |
52 | IKBKE | 0.99077079 |
53 | JAK1 | 0.97279260 |
54 | CSF1R | 0.96811936 |
55 | IRAK2 | 0.96579971 |
56 | TEC | 0.94894165 |
57 | BTK | 0.94465981 |
58 | MAP3K6 | 0.92328458 |
59 | PRKG2 | 0.91453661 |
60 | JAK3 | 0.89148510 |
61 | IRAK4 | 0.88493904 |
62 | MAP3K7 | 0.87549036 |
63 | MAP3K5 | 0.86707469 |
64 | CSK | 0.86280069 |
65 | NME1 | 0.85819408 |
66 | IKBKB | 0.85363607 |
67 | STK10 | 0.84589103 |
68 | MUSK | 0.84090777 |
69 | TAOK1 | 0.83934199 |
70 | MAP3K1 | 0.83364037 |
71 | RPS6KA4 | 0.81188394 |
72 | MATK | 0.78876768 |
73 | JAK2 | 0.78483485 |
74 | MAP2K4 | 0.76863518 |
75 | MAP3K13 | 0.75968506 |
76 | ARAF | 0.75834379 |
77 | PDK3 | 0.73872529 |
78 | PDK4 | 0.73872529 |
79 | MAPK12 | 0.72608461 |
80 | BMX | 0.72558313 |
81 | MET | 0.71673100 |
82 | PAK4 | 0.71056216 |
83 | PRKAA2 | 0.70015044 |
84 | MAP3K10 | 0.70010522 |
85 | MTOR | 0.69107864 |
86 | PDK2 | 0.68267990 |
87 | MAP3K12 | 0.64555183 |
88 | HCK | 0.64207807 |
89 | TGFBR1 | 0.62420906 |
90 | TAOK2 | 0.62007371 |
91 | MOS | 0.60529428 |
92 | MAP2K6 | 0.59924157 |
93 | MAPK4 | 0.58125477 |
94 | PINK1 | 0.57804504 |
95 | CAMK2G | 0.57787091 |
96 | MAP3K2 | 0.57774318 |
97 | DAPK3 | 0.57538333 |
98 | EPHA2 | 0.57121804 |
99 | RPS6KA2 | 0.57095653 |
100 | LATS2 | 0.56743086 |
101 | MAP2K1 | 0.56308193 |
102 | RPS6KA6 | 0.56286716 |
103 | NEK1 | 0.55198307 |
104 | STK4 | 0.54568510 |
105 | MAPK11 | 0.54534749 |
106 | KSR2 | 0.54063550 |
107 | ILK | 0.53426489 |
108 | LIMK1 | 0.52692827 |
109 | CHUK | 0.51101329 |
110 | MAPKAPK2 | 0.50913358 |
111 | MAP2K2 | 0.50347815 |
112 | RPS6KL1 | 0.50029749 |
113 | RPS6KC1 | 0.50029749 |
114 | SYK | 0.48821645 |
115 | PDK1 | 0.47237222 |
116 | EPHA3 | 0.47185966 |
117 | PRKD1 | 0.47104076 |
118 | PTK2 | 0.46783534 |
119 | ITK | 0.44478885 |
120 | MAP3K8 | 0.43892221 |
121 | PRKD2 | 0.43051265 |
122 | SIK3 | 0.42693610 |
123 | PDPK1 | 0.40614807 |
124 | MAPK7 | 0.40558154 |
125 | MAP3K9 | 0.40332993 |
126 | CAMK1D | 0.39496451 |
127 | MARK2 | 0.38766781 |
128 | PIM1 | 0.38765428 |
129 | STK24 | 0.38138763 |
130 | AKT2 | 0.38018366 |
131 | PDGFRA | 0.37310757 |
132 | EGFR | 0.37120262 |
133 | RET | 0.36979095 |
134 | SCYL2 | 0.36040300 |
135 | LCK | 0.35094861 |
136 | RPS6KB2 | 0.34703040 |
137 | PRKAA1 | 0.33634456 |
138 | CAMK2D | 0.31285612 |
139 | RPS6KA1 | 0.30788199 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96639060 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.71210716 |
3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.66678613 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.50083470 |
5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.46827207 |
6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.44109235 |
7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.39361787 |
8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.31356196 |
9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.14753280 |
10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.12395574 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.06489280 |
12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03461665 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.93298167 |
14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80818972 |
15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.77151395 |
16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72705584 |
17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.70742403 |
18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.69036157 |
19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.62773916 |
20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.61390281 |
21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56952823 |
22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.55655740 |
23 | Thyroid cancer_Homo sapiens_hsa05216 | 1.50878944 |
24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50506781 |
25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.50128812 |
26 | Peroxisome_Homo sapiens_hsa04146 | 1.48797321 |
27 | Bladder cancer_Homo sapiens_hsa05219 | 1.47838143 |
28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.44505500 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.39752719 |
30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.32325911 |
31 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.31932782 |
32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.30648128 |
33 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.28523825 |
34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23193619 |
35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21319181 |
36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.20264142 |
37 | Legionellosis_Homo sapiens_hsa05134 | 1.19319179 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17966928 |
39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.17128880 |
40 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.14697240 |
41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14029486 |
42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13664167 |
43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13010382 |
44 | Pertussis_Homo sapiens_hsa05133 | 1.11969997 |
45 | Malaria_Homo sapiens_hsa05144 | 1.10179964 |
46 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.09502917 |
47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08424377 |
48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07890644 |
49 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.06821006 |
50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06734191 |
51 | Insulin resistance_Homo sapiens_hsa04931 | 1.06547561 |
52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05474828 |
53 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.05386120 |
54 | Galactose metabolism_Homo sapiens_hsa00052 | 1.04825928 |
55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00378144 |
56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98625082 |
57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98141753 |
58 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96377324 |
59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96069007 |
60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94995709 |
61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94842785 |
62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.94701363 |
63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.94592817 |
64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94097376 |
65 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.93106184 |
66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92315645 |
67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91783861 |
68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91470803 |
69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88509030 |
70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88425583 |
71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88218236 |
72 | Amoebiasis_Homo sapiens_hsa05146 | 0.87305972 |
73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86072649 |
74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82711692 |
75 | ABC transporters_Homo sapiens_hsa02010 | 0.82447154 |
76 | Lysosome_Homo sapiens_hsa04142 | 0.82430761 |
77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82141691 |
78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80812678 |
79 | Bile secretion_Homo sapiens_hsa04976 | 0.80497066 |
80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80241732 |
81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79665697 |
82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79475500 |
83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79472475 |
84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79122381 |
85 | Tuberculosis_Homo sapiens_hsa05152 | 0.78317559 |
86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.78001590 |
87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.77867502 |
88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75762460 |
89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73680938 |
90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71869370 |
91 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.71269152 |
92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70036094 |
93 | Endocytosis_Homo sapiens_hsa04144 | 0.69966337 |
94 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69914414 |
95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68188645 |
96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67753230 |
97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67577871 |
98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67066986 |
99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.66754283 |
100 | Hepatitis B_Homo sapiens_hsa05161 | 0.66192943 |
101 | Lysine degradation_Homo sapiens_hsa00310 | 0.64980953 |
102 | Platelet activation_Homo sapiens_hsa04611 | 0.64788008 |
103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63776376 |
104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63691814 |
105 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62160239 |
106 | Salmonella infection_Homo sapiens_hsa05132 | 0.61909351 |
107 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61360208 |
108 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61201641 |
109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60906821 |
110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59535788 |
111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59504008 |
112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58967001 |
113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58618407 |
114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58456525 |
115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57631974 |
116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57601437 |
117 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56746223 |
118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56628897 |
119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53180419 |
120 | Phagosome_Homo sapiens_hsa04145 | 0.52123364 |
121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51505136 |
122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50478863 |
123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49976220 |
124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49394887 |
125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49204589 |
126 | Glioma_Homo sapiens_hsa05214 | 0.48865218 |
127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48559866 |
128 | Influenza A_Homo sapiens_hsa05164 | 0.48022863 |
129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47613786 |
130 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46364725 |
131 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.45845494 |
132 | Apoptosis_Homo sapiens_hsa04210 | 0.45770020 |
133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45308340 |
134 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44991320 |
135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44613807 |
136 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43101981 |
137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42896722 |
138 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42641536 |
139 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.42190487 |
140 | Focal adhesion_Homo sapiens_hsa04510 | 0.41873090 |
141 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41396006 |
142 | Hepatitis C_Homo sapiens_hsa05160 | 0.39225684 |
143 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39138521 |
144 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37986535 |
145 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37409250 |
146 | Shigellosis_Homo sapiens_hsa05131 | 0.37082155 |